Browse by category

Allurion Technologies is relaunching the Allurion Balloon in France after the Agence nationale de sécurité du médicament et des produits...

Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...

Allurion Technologies has announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an...

Allurion Technologies has revealed data from a study of 121 patients across 11 obesity centres treated with two consecutive, four-month...

Allurion Technologies has announced that the Somerset NHS Foundation Trust is the first NHS trust in the UK - and the first non-private...

Allurion Technologies has completed patient enrolment in its AUDACITY trial, a randomised, pivotal controlled trial designed to support...

Allurion Technologies has launched Coach Iris, a new generative AI-powered health coach designed to enhance outcomes within the Allurion...

Allurion Technologies and Compute Health Acquisition have entered into a definitive business combination agreement that will result in...

New clinical data on the Allurion Program presented at ObesityWeek 2021 has shown that patients had an average haemoglobin A1c reduction...

Allurion Technologies has transformed its Allurion Weight Loss Program and new worldwide brand for the company and its programme....